January 21, 2023 Comments Off on New patent for Lundbeck Pharms drug CARNEXIV Posted in: Patent Added Annual Drug Patent Expirations for CARNEXIV Carnexiv is a drug marketed by Lundbeck Pharms Llc and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Lundbeck Pharms drug CARNEXIV appeared first on DrugPat…
January 20, 2023 Comments Off on New patent for Biofrontera drug AMELUZ Posted in: Patent Added Annual Drug Patent Expirations for AMELUZ Ameluz is a drug marketed by Biofrontera and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Biofrontera drug AMELUZ appeared first on DrugPate…